Detalhe da pesquisa
1.
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Hematol Oncol;
40(4): 704-715, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35608183
2.
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
Eur J Haematol;
108(3): 178-189, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34716957
3.
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
Haematologica;
106(1): 291-294, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32107338
4.
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI ) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma.
Br J Haematol;
166(1): 118-29, 2014 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24673727
5.
Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma.
Eur J Nucl Med Mol Imaging;
41(5): 867-77, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24435772
6.
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.
Cancers (Basel);
16(6)2024 Mar 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38539561
7.
Treatment of Acute Hepatitis C With Ledipasvir and Sofosbuvir in Patients With Hematological Malignancies Allows Early Re-start of Chemotherapy.
Clin Gastroenterol Hepatol;
16(6): 977-978, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29104131
8.
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel.
Hemasphere;
7(6): e891, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37234822
9.
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.
Target Oncol;
18(6): 885-892, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37747623
10.
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.
Br J Haematol;
156(2): 234-44, 2012 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22098541
11.
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials.
Front Oncol;
12: 890376, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35924160
12.
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.
Br J Haematol;
154(5): 579-89, 2011 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21707585
13.
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.
Eur J Haematol;
87(6): 547-53, 2011 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21752099
14.
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers.
Cancers (Basel);
13(5)2021 Feb 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33669053
15.
Expression of the brain transcription factor OTX1 occurs in a subset of normal germinal-center B cells and in aggressive Non-Hodgkin Lymphoma.
Am J Pathol;
175(6): 2609-17, 2009 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19893048
16.
Decision criteria for rational selection of homogeneous genotyping platforms for pharmacogenomics testing in clinical diagnostics.
Clin Chem Lab Med;
48(4): 447-59, 2010 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20192881
17.
Optimization of a Low-Cost, Sensitive PNA Clamping PCR Method for JAK2 V617F Variant Detection.
J Appl Lab Med;
5(4): 643-655, 2020 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32407536
18.
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients.
Cells;
8(7)2019 07 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31269695
19.
Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy.
Curr Cancer Drug Targets;
18(5): 499-511, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28183252
20.
Richter Syndrome With Plasmablastic Lymphoma at Primary Diagnosis: A Case Report With a Review of the Literature.
Appl Immunohistochem Mol Morphol;
25(6): e40-e45, 2017 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27801729